✦ LIBER ✦
[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] A101. PHARMACOLOGICAL TREATMENT OF COPD: OLD AND NEW - Pearl Therapeutics' Combination LAMA/LABA MDI (GFF-MDI, PT003) Provides A Significant Benefit On Home Peak Expiratory Flow Rate (PEFR) And Reduces The Need For Rescue Albuterol Use Compared To Its Components Administered Alone, Spiriva® Handihaler®, And Foradil® Aerolizer® In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD
✍ Scribed by Reisner, Colin; Rennard, Stephen I.; Fogarty, Charles; Fischer, Tracy; Rose, Earl St; Fernandez, Carlos; Orevillo, Chad
- Book ID
- 125511020
- Publisher
- American Thoracic Society
- Year
- 2012
- Weight
- 20 KB
- Category
- Article
No coin nor oath required. For personal study only.